Effects of Novel Dual GIP and GLP-1 Receptor Agonist, Tirzepatide, on Biomarkers of Non-Alcoholic Steatohepatitis in Patients with T2DM
暂无分享,去创建一个
K. Duffin | A. Sanyal | R. Loomba | M. Hartman | D. Robins | A. Haupt | C. Karanikas | J. Wilson | R. Bray | Amir Nikooienejad